Zobrazeno 1 - 10
of 18
pro vyhledávání: '"A. Sideri-Gugger"'
Publikováno v:
International Journal of Endocrinology, Vol 2023 (2023)
Context. Numerous reports suggest an association between SGLT2 inhibitors and DKA. Since the use of these drugs for diabetes has increased dramatically, identification of patients at greatest risk of this life-threatening complication is essential. O
Externí odkaz:
https://doaj.org/article/d884fb44985d46b7bae7e92bc69ac449
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Aristea Sideri Gugger, Cara Dimino, Sunil K Panigrahi, Laurel Mayer, Richard M Smiley, Judith Korner, Sharon L Wardlaw
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism.
Context Individual responses to weight loss (WL) medications vary widely and prediction of response remains elusive. Objective We investigated biomarkers associated with use of lorcaserin (LOR), a 5HT2cR agonist that targets proopiomelanocortin (POMC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1d16b9f5247628ddb40464851a7b70ed
https://doi.org/10.1210/clinem/dgad139
https://doi.org/10.1210/clinem/dgad139
Publikováno v:
JCEM Case Reports. 1
Delayed diagnosis of Cushing syndrome (CS) results in advanced disease, treatment delays, and poor outcomes. We present a patient with ectopic ACTH syndrome (EAS) from a pancreatic neuroendocrine tumor (NET) whose care posed diagnostic and therapeuti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::550d4e8e8e1deb69f298061bb2125927
https://doi.org/10.1210/jcemcr/luad022
https://doi.org/10.1210/jcemcr/luad022
Autor:
Sideri Gugger, Aristea, Dimino, Cara, Panigrahi, Sunil K, Mayer, Laurel, Smiley, Richard M, Korner, Judith, Wardlaw, Sharon L
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism; September 2023, Vol. 108 Issue: 9 p2262-2271, 10p
Autor:
Aristea Sideri Gugger, Jiali Fang, Renu Virk, Umar Ahmad, Jorge Ariazza Sagredo, Kavel H Visrodia, Gabrielle Page Wilson
Publikováno v:
Journal of the Endocrine Society. 6:A536-A537
Background The delayed diagnosis of Cushing's syndrome (CS) results in advanced disease, treatment delays and poor outcomes. We present a patient with ectopic ACTH-syndrome (EAS) from a pancreatic neuroendocrine tumor (NET) whose care posed significa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dcc102a457b6ed34c5896c8cad16f982
https://doi.org/10.1210/jendso/bvac150.1116
https://doi.org/10.1210/jendso/bvac150.1116
Publikováno v:
Journal of the Endocrine Society
Background Identifying the etiology of hormonal insufficiency is important for correct diagnosis and for appropriate hormone supplementation. Usually multiple hormone deficiencies are driven by pituitary pathology, but here we present a case that pos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::baedd84e791a7306246979ca49c21778
http://europepmc.org/articles/PMC7207994
http://europepmc.org/articles/PMC7207994
Publikováno v:
Journal of the Endocrine Society
Background Unintentional weight loss, ascites, and altered mental status typically raise concerns for hepatologic-cardiac-oncologic disease. Herein we present a case that after exhaustive workup the etiology of the aforementioned findings was attribu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42dabf47e7540bc7c23fbaee8dfba29b
https://doi.org/10.1210/jendso/bvaa046.1790
https://doi.org/10.1210/jendso/bvaa046.1790
Autor:
Aristea Sideri Gugger, Mehreen Elahee, Kinjal Kasbawala, Sachin Majumdar, George A. Stamatiades
Publikováno v:
Journal of the Endocrine Society
Introduction Sodium glucose co-transporter 2 (SGLT2) inhibitors have become an appealing treatment for diabetes due to their favorable cardiac and renal outcomes. However, reports continue to emerge describing potentially life-threatening adverse eve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::603e26d802603c598d4e18f5ff2c2982
https://doi.org/10.1210/jendso/bvaa046.984
https://doi.org/10.1210/jendso/bvaa046.984
Autor:
Aristea Sideri Gugger, George A. Stamatiades, Gracia Viana, Silvia Vilarinho, Sachin Majumdar, Mehreen Elahee
Publikováno v:
Journal of the Endocrine Society
Background Leptin is an adipocyte-derived peptide hormone that acts in the hypothalamus to stimulate pathways that inhibit feeding and promote energy expenditure. Mutations in the gene encoding leptin or its receptor (LR) are rare and typically lead
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f49b515f86efbbd5aa01007cce220ea
https://doi.org/10.1210/js.2019-sat-088
https://doi.org/10.1210/js.2019-sat-088